ibandronic acid has been researched along with Osteolysis in 12 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (8.33) | 18.2507 |
2000's | 8 (66.67) | 29.6817 |
2010's | 3 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrenfeld, M; Mayr, D; Oduncu, F; Otto, S; Pautke, C; Troeltzsch, M | 1 |
Chung, YS; Kang, HC; Lee, T | 1 |
Lo, JC; O'Ryan, FS | 1 |
DeClerck, YA; Pollack, H; Reynolds, CP; Scadeng, M; Shimada, H; Sohara, Y; Yamada, S; Ye, W | 1 |
Bauss, F; Fischer, C; Krempien, B; Neudert, M; Seibel, MJ | 1 |
Kurth, AH | 1 |
Bauss, F; Bian, H; Garces, A; Jenkins, J; Kim, HK; Randall, TS | 1 |
Bauss, F; Ghilardi, JR; Halvorson, KG; Koewler, NJ; Mantyh, PW; Sevcik, MA; Sullivan, LJ | 1 |
Bauss, F; De Clerck, YA; Dunstan, C; Mundy, GR; Sasaki, A; Williams, PJ; Yoneda, T | 1 |
Bauss, F; Juraschek, M; Krempien, B; Seibel, MJ; Woitge, HW | 1 |
Alsina, M; Anderson, JL; Craig, F; Cruz, JC; Dallas, M; Roodman, GD; Yoneda, T | 1 |
Bauss, F; Kim, SZ; Kurth, AA; Sedlmeyer, I; Shea, M | 1 |
1 review(s) available for ibandronic acid and Osteolysis
Article | Year |
---|---|
Root resorption caused by jaw infiltration of multiple myeloma: report of a case and literature review.
Topics: Aged; Antineoplastic Agents; Bicuspid; Bone Density Conservation Agents; Diphosphonates; Follow-Up Studies; Humans; Ibandronic Acid; Male; Mandibular Neoplasms; Molar; Multiple Myeloma; Neoplasm Invasiveness; Osteolysis; Root Resorption; Stem Cell Transplantation; Tooth Mobility | 2014 |
11 other study(ies) available for ibandronic acid and Osteolysis
Article | Year |
---|---|
Comparative Effects of Ibandronate and Paclitaxel on Immunocompetent Bone Metastasis Model.
Topics: Amino Acids; Animals; Biomechanical Phenomena; Bone Density; Bone Neoplasms; Bone Resorption; Diphosphonates; Ibandronic Acid; Immunocompetence; Male; Neoplasm Metastasis; Osteolysis; Paclitaxel; Rats; Rats, Sprague-Dawley | 2015 |
Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alendronate; Anti-Bacterial Agents; Antirheumatic Agents; Bisphosphonate-Associated Osteonecrosis of the Jaw; Bone Density Conservation Agents; Bone Diseases, Metabolic; Chronic Disease; Cohort Studies; Debridement; Diphosphonates; Female; Follow-Up Studies; Glucocorticoids; Humans; Ibandronic Acid; Male; Middle Aged; Osteolysis; Osteoporosis; Osteosclerosis; Retrospective Studies; Tooth Extraction; Treatment Outcome; Wound Healing | 2012 |
Lytic bone lesions in human neuroblastoma xenograft involve osteoclast recruitment and are inhibited by bisphosphonate.
Topics: Adrenal Glands; Animals; Apoptosis; Bone Neoplasms; Diphosphonates; Female; Femoral Neoplasms; Femur; Heart; Humans; Ibandronic Acid; Injections; Injections, Intravenous; Injections, Subcutaneous; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neuroblastoma; Osteoclasts; Osteolysis; Tail; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2003 |
Site-specific human breast cancer (MDA-MB-231) metastases in nude rats: model characterisation and in vivo effects of ibandronate on tumour growth.
Topics: Animals; Apoptosis; Bone Density; Bone Neoplasms; Diphosphonates; Female; Humans; Ibandronic Acid; Mammary Neoplasms, Experimental; Neoplasm Transplantation; Osteolysis; Rats; Rats, Nude; Rats, Sprague-Dawley; Transplantation, Heterologous | 2003 |
[Oral and parenteral forms of aminobisphosphonate].
Topics: Administration, Oral; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Colorectal Neoplasms; Diphosphonates; Humans; Ibandronic Acid; Infusions, Intravenous; Osteolysis; Spinal Neoplasms | 2004 |
Ibandronate for prevention of femoral head deformity after ischemic necrosis of the capital femoral epiphysis in immature pigs.
Topics: Animals; Bone Resorption; Diphosphonates; Epiphyses; Femur Head; Femur Head Necrosis; Ibandronic Acid; Infarction; Ischemia; Male; Osteolysis; Radiography; Swine | 2005 |
Intravenous ibandronate rapidly reduces pain, neurochemical indices of central sensitization, tumor burden, and skeletal destruction in a mouse model of bone cancer.
Topics: Animals; Biomarkers, Tumor; Bone Density Conservation Agents; Bone Neoplasms; Cell Line, Tumor; Diphosphonates; Disease Models, Animal; Ibandronic Acid; Injections, Intravenous; Male; Mice; Mice, Inbred C3H; Osteolysis; Osteosarcoma; Pain; Pain Measurement; Treatment Outcome | 2008 |
Inhibition of osteolytic bone metastasis of breast cancer by combined treatment with the bisphosphonate ibandronate and tissue inhibitor of the matrix metalloproteinase-2.
Topics: Animals; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Breast Neoplasms; Cell Survival; Diphosphonates; Female; Genetic Therapy; Heart Ventricles; Humans; Ibandronic Acid; Mice; Mice, Nude; Neoplasm Invasiveness; Osteolysis; Protein Biosynthesis; Tibia; Tissue Inhibitor of Metalloproteinase-2; Transfection; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
Topics: Animals; Biomarkers; Carcinoma 256, Walker; Diphosphonates; Female; Ibandronic Acid; Longitudinal Studies; Models, Biological; Osteolysis; Parathyroid Hormone-Related Protein; Proteins; Rats; Rats, Wistar | 2000 |
Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma.
Topics: Animals; Bone Diseases; Bone Marrow Cells; Cell Division; Cell Survival; Diphosphonates; Disease Models, Animal; Humans; Hypercalcemia; Ibandronic Acid; Immunoglobulin G; Immunoglobulin kappa-Chains; Leukemia, Plasma Cell; Mice; Mice, SCID; Multiple Myeloma; Neoplasm Transplantation; Osteoclasts; Osteolysis; Paraplegia; Tumor Cells, Cultured | 2001 |
Ibandronate treatment decreases the effects of tumor-associated lesions on bone density and strength in the rat.
Topics: Animals; Biomechanical Phenomena; Bone Density; Bone Neoplasms; Diphosphonates; Female; Fractures, Bone; Humans; Ibandronic Acid; Mammary Neoplasms, Experimental; Osteolysis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental | 2002 |